Bausch & Lomb (BLCO) Retained Earnings (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Retained Earnings came in at -$1.2 billion in Q2 2026, down 2.27% on a YoY basis from -$1.2 billion in Q2 2025, and down 1.58% quarter-over-quarter from -$1.2 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Retained Earnings (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Retained Earnings for 6 consecutive years, with -$1.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings fell 2.27% year-over-year to -$1.2 billion; the trailing twelve-month figure through Jun 2026 stood at -$1.2 billion (down 2.27% YoY), and the FY2025 full-year result was -$1.2 billion, up 14.51% from the prior year.
- Retained Earnings slipped to -$1.2 billion in Q2 2026 per BLCO's latest filing, from -$1.2 billion in the prior quarter.
- Across five years, Retained Earnings topped out at -$1.1 billion in Q1 2022 and bottomed at -$1.4 billion in Q3 2022.
- Historically, Retained Earnings has averaged -$1.3 billion across 5 years, with a median of -$1.2 billion in 2023.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 13760.0% in 2022, then grew 14.51% in 2025.
- Over 5 years, Retained Earnings stood at -$1.3 billion in 2022, then rose by 1.03% to -$1.2 billion in 2023, then decreased by 11.24% to -$1.4 billion in 2024, then gained by 14.51% to -$1.2 billion in 2025, then dropped by 2.87% to -$1.2 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$1.2 billion, -$1.2 billion, and -$1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | -1.22 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.22 Bn |
| Mar 31, 2026 | -1.20 Bn |
| Dec 31, 2025 | -1.18 Bn |
| Sep 30, 2025 | -1.20 Bn |
| Jun 30, 2025 | -1.19 Bn |
| Mar 31, 2025 | -1.30 Bn |
| Dec 31, 2024 | -1.39 Bn |
| Sep 30, 2024 | -1.25 Bn |
| Jun 30, 2024 | -1.31 Bn |
| Mar 31, 2024 | -1.28 Bn |
| Dec 31, 2023 | -1.25 Bn |
| Sep 30, 2023 | -1.32 Bn |
| Jun 30, 2023 | -1.25 Bn |
| Mar 31, 2023 | -1.24 Bn |
| Dec 31, 2022 | -1.26 Bn |
| Sep 30, 2022 | -1.39 Bn |
| Jun 30, 2022 | -1.22 Bn |
| Mar 31, 2022 | -1.10 Bn |
| Dec 31, 2021 | -1.04 Bn |
| Sep 30, 2021 | -10.00 Mn |